Global RNA Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global RNA Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.
Global RNA Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Research Institutions are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for RNA Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, RNA Therapeutics key companies include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals and BioNTech, etc. Moderna, Alnylam Pharmaceuticals, Novartis are top 3 players and held % share in total in 2022.
RNA Therapeutics can be divided into mRNA, RNA Interference (RNAi), Antisense Oligonucleotide (ASO) and Other, etc. mRNA is the mainstream product in the market, accounting for % share globally in 2022.
RNA Therapeutics is widely used in various fields, such as Hospitals and Research Institutions, etc. Hospitals provides greatest supports to the RNA Therapeutics industry development. In 2022, global % share of RNA Therapeutics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Segment by Type
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other
Hospitals
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the RNA Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, RNA Therapeutics introduction, etc. RNA Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of RNA Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global RNA Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Research Institutions are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for RNA Therapeutics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, RNA Therapeutics key companies include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals and BioNTech, etc. Moderna, Alnylam Pharmaceuticals, Novartis are top 3 players and held % share in total in 2022.
RNA Therapeutics can be divided into mRNA, RNA Interference (RNAi), Antisense Oligonucleotide (ASO) and Other, etc. mRNA is the mainstream product in the market, accounting for % share globally in 2022.
RNA Therapeutics is widely used in various fields, such as Hospitals and Research Institutions, etc. Hospitals provides greatest supports to the RNA Therapeutics industry development. In 2022, global % share of RNA Therapeutics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Segment by Type
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other
Segment by Application
Hospitals
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the RNA Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, RNA Therapeutics introduction, etc. RNA Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of RNA Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices